AGA GUIDELINES Bundle (free trial)

Bowel Cleansing

AGA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/809940

Contents of this Issue

Navigation

Page 3 of 7

Rating the Quality of Bowel Preparation During Colonoscopy ➤ Adequacy of bowel preparation should be assessed after all appropriate efforts to clear residual debris have been completed. (Strong; Low Quality of Evidence) ➤ Measurement of the rate of adequate colon cleansing should be conducted routinely. (Strong; Moderate Quality of Evidence) ➤ Adequate preparation, defined as cleansing that allows a recommendation of a screening or surveillance interval appropriate to the findings of the examination, should be achieved in 85% or more of all examinations on a per-physician basis. (Strong; Low Quality of Evidence) FDA-Approved Preparations ➤ Selection of a bowel-cleansing regimen should take into consideration the patient's medical history, medications, and, when available, the adequacy of bowel preparation reported from prior colonoscopies. (Strong; Moderate Quality of Evidence) ➤ A split-dose regimen of 4 L PEG-ELS provides high-quality bowel cleansing. (Strong; High Quality of Evidence) ➤ In healthy nonconstipated individuals, a 4-L PEG-ELS formulation produces a bowel-cleansing quality that is not superior to a lower-volume PEG formulation. (Strong; High Quality of Evidence) OTC Non–FDA-Approved Preparations ➤ The OTC bowel cleansing agents have variable efficacy that ranges from adequate to superior, depending on the agent, dose, timing of administration, and whether it is used alone or in combination. Regardless of the agent, the efficacy and tolerability are enhanced with a split-dose regimen. (Strong; Moderate Quality of Evidence) ➤ Although the OTC purgatives generally are safe, caution is required when using these agents in certain populations — for example, magnesium- based preparations (both OTC and FDA-approved formulations) should be avoided in patients with chronic kidney disease. (Weak; Very Low Quality of Evidence) Adjuncts to Colon Cleansing Before Colonoscopy ➤ The routine use of adjunctive agents for bowel cleansing before colonoscopy is NOT recommended. (Weak; Moderate Quality of Evidence) Recommendations

Articles in this issue

Archives of this issue

view archives of AGA GUIDELINES Bundle (free trial) - Bowel Cleansing